{"entity":{"type":"insider","cik":"0001927032","url":"/insider/0001927032","json_url":"/insider/0001927032.json","name":"Stockwell Lynn","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2023-09-06","last":"2025-10-01","span_basis":"filed_date"},"name_variants":[{"name":"Stockwell Lynn","source":"filing","n_filings":5,"first_seen":"2023-09-06","last_seen":"2025-10-01"}],"transactions":[{"id":4172401,"accession":"0001213900-25-094436","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-25-094436","line_url":"/filing/0001213900-25-094436#line-3","is_derivative":false,"issuer_cik":"0001927032","issuer_name":"Drugs Made In America Acquisition II Corp.","issuer_ticker":"DMII","issuer_name_source":null,"issuer_url":"/issuer/0001927032","owner_cik":"0001927032","owner_name":"Stockwell Lynn","owner_display_name":"Stockwell Lynn","owner_url":"/insider/0001927032","role":"Director, Officer (CEO and Exe. Chair of Board), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Exe. Chair of Board","security_title":"Ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7966667.0,"shares_display":"7,966,667","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":6708333.0,"shares_owned_after_display":"6,708,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-10-01","scope":"insider"},{"id":4172397,"accession":"0001213900-25-094436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-094436","line_url":"/filing/0001213900-25-094436#line-2","is_derivative":false,"issuer_cik":"0001927032","issuer_name":"Drugs Made In America Acquisition II Corp.","issuer_ticker":"DMII","issuer_name_source":null,"issuer_url":"/issuer/0001927032","owner_cik":"0001927032","owner_name":"Stockwell Lynn","owner_display_name":"Stockwell Lynn","owner_url":"/insider/0001927032","role":"Director, Officer (CEO and Exe. Chair of Board), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Exe. Chair of Board","security_title":"Ordinary shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700000.0,"shares_display":"700,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":15075000.0,"shares_owned_after_display":"15,075,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-10-01","scope":"insider"},{"id":4491681,"accession":"0001213900-25-015019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-25-015019","line_url":"/filing/0001213900-25-015019#line-1","is_derivative":false,"issuer_cik":"0001927032","issuer_name":"Drugs Made In America Acquisition Corp.","issuer_ticker":"DMAA","issuer_name_source":null,"issuer_url":"/issuer/0001927032","owner_cik":"0001927032","owner_name":"Stockwell Lynn","owner_display_name":"Stockwell Lynn","owner_url":"/insider/0001927032","role":"Director, Officer (CEO and Exe. Chair of Board), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Exe. Chair of Board","security_title":"Ordinary shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":4188780.0,"shares_owned_after_display":"4,188,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-18","scope":"insider"},{"id":4373191,"accession":"0001213900-25-010193","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-25-010193","line_url":"/filing/0001213900-25-010193#line-3","is_derivative":false,"issuer_cik":"0001927032","issuer_name":"Drugs Made In America Acquisition Corp.","issuer_ticker":"DMAA","issuer_name_source":null,"issuer_url":"/issuer/0001927032","owner_cik":"0001927032","owner_name":"Stockwell Lynn","owner_display_name":"Stockwell Lynn","owner_url":"/insider/0001927032","role":"Director, Officer (CEO and Executive COB), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Executive COB","security_title":"Ordinary shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5698363.0,"shares_display":"5,698,363","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":4158780.0,"shares_owned_after_display":"4,158,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-02-04","scope":"insider"},{"id":4373184,"accession":"0001213900-25-010193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-25-010193","line_url":"/filing/0001213900-25-010193#line-2","is_derivative":false,"issuer_cik":"0001927032","issuer_name":"Drugs Made In America Acquisition Corp.","issuer_ticker":"DMAA","issuer_name_source":null,"issuer_url":"/issuer/0001927032","owner_cik":"0001927032","owner_name":"Stockwell Lynn","owner_display_name":"Stockwell Lynn","owner_url":"/insider/0001927032","role":"Director, Officer (CEO and Executive COB), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and Executive COB","security_title":"Ordinary shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":10257.143,"shares_owned_after_display":"10,257.14","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-02-04","scope":"insider"},{"id":3081462,"accession":"0001493152-24-023290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-023290","line_url":"/filing/0001493152-24-023290#line-1","is_derivative":false,"issuer_cik":"0001886799","issuer_name":"Bright Green Corp","issuer_ticker":"BGXX","issuer_name_source":null,"issuer_url":"/issuer/0001886799","owner_cik":"0001927032","owner_name":"Stockwell Lynn","owner_display_name":"Stockwell Lynn","owner_url":"/insider/0001927032","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000000.0,"shares_display":"1,000,000","price_per_share":0.3597,"price_display":"0.36","price_state":"stated","total_value":359700.0,"total_display":"359,700.00","total_whole":"359,700","shares_owned_after":68183658.0,"shares_owned_after_display":"68,183,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-05","filed_date":"2024-06-10","scope":"insider"},{"id":7942847,"accession":"0001493152-23-031869","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001493152-23-031869","line_url":"/filing/0001493152-23-031869#line-3","is_derivative":false,"issuer_cik":"0001886799","issuer_name":"Bright Green Corp","issuer_ticker":"BGXX","issuer_name_source":null,"issuer_url":"/issuer/0001886799","owner_cik":"0001927032","owner_name":"Stockwell Lynn","owner_display_name":"Stockwell Lynn","owner_url":"/insider/0001927032","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":0.4667,"price_display":"0.47","price_state":"stated","total_value":116675.0,"total_display":"116,675.00","total_whole":"116,675","shares_owned_after":66355698.0,"shares_owned_after_display":"66,355,698","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-09-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002040475","name":"Drugs Made In America Acquisition II Corp.","url":"/issuer/0002040475","role":"Director, Officer (CEO and Exe. Chair of Board), Ten percent owner","n_filings":1,"first_seen":"2025-10-01","last_seen":"2025-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0002028614","name":"Drugs Made In America Acquisition Corp.","url":"/issuer/0002028614","role":"Director, Officer (CEO and Exe. Chair of Board), Ten percent owner","n_filings":2,"first_seen":"2025-02-04","last_seen":"2025-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001886799","name":"Bright Green Corp","url":"/issuer/0001886799","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2023-09-06","last_seen":"2024-06-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001927032","retrieved_at":"2026-08-25T11:07:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}